Lance Berman, Chief Medical Officer and SVP at Relypsa Inc (RLYP), sold 30,750 shares at $29.78 ($916K) on 2015-12-07, disclosed to the SEC on 2015-12-09.
Scheduled sale ($916k) by Chief Medical Officer and SVP under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.78 | 30,000 | $893K | 97.6% |
| 2 | $29.50 | 750 | $22K | 2.4% |
| Total | $29.77 avg | 30,750 | $916K | 100% |
| Filing → |
| RLYP | SELL | 2014-12-02 | $125K | — | Filing → |
| RLYP | SELL | 2014-11-26 | $750K | — | Filing → |
| RLYP | SELL | 2014-09-25 | $110K | — | Filing → |